Jia-Jie Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jia-Jie Lu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- En-Qiang Chen
Center of Infectious Diseases, West China Hospital of Sichuan University
1 shared publication - Hong Tang
Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication - Jia-Hong Yang
Department of Infectious diseases, People's Hospital of Deyang City, Deyang City, China
1 shared publication - Li Liu
Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China
1 shared publication - Tao-You Zhou
Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 10 January 2012
- Published by Springer Nature in Virology Journal
- Vol. 9 (1) , 10
A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients
A functional interferon regulatory element (IRE) has been found in the EnhI/X promoter region of hepatitis B virus (HBV) genome. The purpose of this study is to compare the gene order of responder and non-responder to interferon therapy in patients with chronic hepatitis B (CHB), so as to evaluate the relationship between IRE mutation and the response to interferon treatment for CHB patients.
- 10 January 2012
- Published by Springer Nature in Virology Journal
- Vol. 9 (1) , 10
Open AccessA mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients
A functional interferon regulatory element (IRE) has been found in the EnhI/X promoter region of hepatitis B virus (HBV) genome. The purpose of this study is to compare the gene order of responder and non-responder to interferon therapy in patients with chronic hepatitis B (CHB), so as to evaluate the relationship between IRE mutation and the response to interferon treatment for CHB patients.